FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | National Business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--

Related Keywords

South San Francisco ,California ,United States ,Adam Pryor ,Loren Kalm ,Levi Garraway ,Gina Truslow ,Bruno Eschli ,Global Product Development ,European Hematology Association ,Roche Group ,Genentech ,Chugai Pharmaceutical Co Ltd ,Drug Administration ,Biologics License Application ,Global Product ,Media Contact ,Business Wire ,National Business ,